Emmessar Biotech & Nutrition Limited (BOM:524768)
India · Delayed Price · Currency is INR 29.43
-1.31 (-4.26%)
At close: Jul 29, 2025
BOM:524768 Revenue
In the fiscal year ending March 31, 2025, Emmessar Biotech & Nutrition had annual revenue of 26.20M INR with 28.31% growth. Emmessar Biotech & Nutrition had revenue of 7.04M in the quarter ending March 31, 2025, with 1,207.81% growth.
Revenue
26.20M
Revenue Growth
+28.31%
P/S Ratio
5.67
Revenue / Employee
1.54M
Employees
17
Market Cap
148.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.20M | 5.78M | 28.31% |
| Mar 31, 2024 | 20.42M | -4.73M | -18.82% |
| Mar 31, 2023 | 25.15M | 7.42M | 41.83% |
| Mar 31, 2022 | 17.73M | -66.83M | -79.03% |
| Mar 31, 2021 | 84.56M | 37.03M | 77.89% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 631.21B |